Cidara (CDTX) Climbs 105% on $9.2-Billion Merger with Merck

We recently published 10 Market Movers That Made Millionaires in a Week. Cidara Therapeutics Inc. (NASDAQ:CDTX) is one of the best-performing stocks of the past trading week. Cidara Therapeutics soared by more than 100 percent week-on-week, as investors repositioned portfolios following news that it is set to be acquired by Merck Co. for $9.2 billion. On Friday alone, Cidara Therapeutics Inc. (NASDAQ:CDTX) climbed to as high as $218.85 before trimming gains to end the day just up by 105.41 percent at $21 ...